Kraton (NYSE:KRA) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Friday.

Other research analysts also recently issued research reports about the company. KeyCorp reissued a “hold” rating on shares of Kraton in a report on Friday, September 1st. Zacks Investment Research raised Kraton from a “hold” rating to a “buy” rating and set a $47.00 price target for the company in a report on Tuesday, October 17th. BidaskClub downgraded Kraton from a “buy” rating to a “hold” rating in a report on Friday, August 11th. SunTrust Banks reissued a “buy” rating and issued a $55.00 price target (up previously from $45.00) on shares of Kraton in a report on Wednesday, October 11th. They noted that the move was a valuation call. Finally, TheStreet cut Kraton from a “b-” rating to a “c” rating in a research note on Wednesday, October 25th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $51.50.

Shares of Kraton (NYSE:KRA) opened at $46.73 on Friday. Kraton has a 1 year low of $25.09 and a 1 year high of $51.23. The company has a quick ratio of 1.19, a current ratio of 2.27 and a debt-to-equity ratio of 2.85. The firm has a market capitalization of $1,462.46, a PE ratio of 18.92 and a beta of 1.19.

Kraton (NYSE:KRA) last issued its earnings results on Tuesday, October 24th. The specialty chemicals company reported $1.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.94 by $0.57. Kraton had a return on equity of 14.19% and a net margin of 1.27%. The company had revenue of $510.90 million during the quarter, compared to the consensus estimate of $481.77 million. During the same quarter in the prior year, the business earned $0.63 earnings per share. The company’s revenue was up 12.5% compared to the same quarter last year. research analysts expect that Kraton will post 2.96 EPS for the current fiscal year.

In other news, Director Barry J. Goldstein sold 16,651 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $49.15, for a total transaction of $818,396.65. Following the sale, the director now directly owns 42,323 shares in the company, valued at approximately $2,080,175.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin Michael Fogarty sold 81,430 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $49.09, for a total value of $3,997,398.70. Following the sale, the chief executive officer now owns 278,119 shares in the company, valued at $13,652,861.71. The disclosure for this sale can be found here. Insiders have sold a total of 218,614 shares of company stock worth $10,434,139 over the last quarter. Insiders own 4.71% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Rubric Capital Management LP increased its position in Kraton by 509.1% in the 3rd quarter. Rubric Capital Management LP now owns 607,952 shares of the specialty chemicals company’s stock valued at $24,586,000 after acquiring an additional 508,140 shares during the period. Algert Global LLC acquired a new stake in Kraton in the 3rd quarter valued at approximately $495,000. Uniplan Investment Counsel Inc. increased its position in Kraton by 45.8% in the 3rd quarter. Uniplan Investment Counsel Inc. now owns 237,590 shares of the specialty chemicals company’s stock valued at $9,608,000 after acquiring an additional 74,590 shares during the period. Magnetar Financial LLC acquired a new stake in Kraton in the 3rd quarter valued at approximately $232,000. Finally, Dimensional Fund Advisors LP increased its position in Kraton by 0.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,631,627 shares of the specialty chemicals company’s stock valued at $106,419,000 after acquiring an additional 13,374 shares during the period. Hedge funds and other institutional investors own 97.53% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was first reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/12/03/kraton-kra-rating-lowered-to-buy-at-valuengine.html.

About Kraton

Kraton Corporation, formerly Kraton Performance Polymers, Inc, is a specialty chemicals company. The Company manufactures styrenic block copolymers (SBCs) and other engineered polymers. The Company also produces specialty products primarily derived from pine wood pulping co-products. The Company operates through two segments: Polymer Segment, which comprises SBCs and other engineered polymers business, and Chemical Segment, which comprises pine-based specialty products business.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Kraton Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kraton Corporation and related companies with MarketBeat.com's FREE daily email newsletter.